An Australian experience using Tc‐PSMA SPECT/CT in the primary diagnosis of prostate cancer and for staging at biochemical recurrence after local therapy
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
An Australian experience using Tc‐PSMA SPECT/CT in the primary diagnosis of prostate cancer and for staging at biochemical recurrence after local therapy
Authors
Keywords
-
Journal
PROSTATE
Volume 83, Issue 10, Pages 970-979
Publisher
Wiley
Online
2023-04-13
DOI
10.1002/pros.24538
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Primary tumour PSMA intensity is an independent prognostic biomarker for biochemical recurrence-free survival following radical prostatectomy
- (2022) Matthew J. Roberts et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- 68Ga-PSMA-11 PET/MRI in patients with newly diagnosed intermediate or high-risk prostate adenocarcinoma: PET findings correlate with outcomes after definitive treatment
- (2022) Farshad Moradi et al. JOURNAL OF NUCLEAR MEDICINE
- Diagnostic performance and clinical impact of 68Ga-PSMA-11 imaging in early relapsed prostate cancer after radical therapy: a prospective multicenter study (IAEA-PSMA study).
- (2021) Juliano Julio Cerci et al. JOURNAL OF NUCLEAR MEDICINE
- Head-to-head comparison of 68Ga-PSMA-11 PET/CT and mpMRI with histopathology gold-standard in the detection, intra-prostatic localization and local extension of primary prostate cancer: results from a prospective single-center imaging trial
- (2021) Ida Sonni et al. JOURNAL OF NUCLEAR MEDICINE
- Risk of metastatic disease using [18F]PSMA-1007 PET/CT for primary prostate cancer staging
- (2021) Venkata Avinash Chikatamarla et al. EJNMMI Research
- Multi-phasic 68Ga-PSMA PET/CT in detection of early recurrence in prostate cancer patients with PSA < 1 ng/ml: a prospective study of 135 cases.
- (2020) Mohsen Beheshti et al. JOURNAL OF NUCLEAR MEDICINE
- [99cmTc]Tc-PSMA-I&S-SPECT/CT: experience in prostate cancer imaging in an outpatient center
- (2020) P. Werner et al. EJNMMI Research
- Gallium-68 Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer—Updated Diagnostic Utility, Sensitivity, Specificity, and Distribution of Prostate-specific Membrane Antigen-avid Lesions: A Systematic Review and Meta-analysis
- (2019) Marlon Perera et al. EUROPEAN UROLOGY
- 68Ga-PSMA-11 PET/CT derived quantitative volumetric tumor parameters for classification and evaluation of therapeutic response of bone metastases in prostate cancer patients
- (2019) Christian Schmidkonz et al. ANNALS OF NUCLEAR MEDICINE
- 68Ga-PSMA-11 PET/CT in patients with recurrent prostate cancer—a modified protocol compared with the common protocol
- (2019) Fabian Haupt et al. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING
- Diagnostic value of 68Ga-PSMA PET/CT for detection of PTEN expression in prostate cancer: a pilot study
- (2019) Baojun Wang et al. JOURNAL OF NUCLEAR MEDICINE
- SPECT/CT With the PSMA Ligand 99mTc-MIP-1404 for Whole-Body Primary Staging of Patients With Prostate Cancer
- (2018) Christian Schmidkonz et al. CLINICAL NUCLEAR MEDICINE
- Salivary gland toxicity of PSMA Radioligand Therapy: relevance and preventive strategies
- (2018) Thomas Langbein et al. JOURNAL OF NUCLEAR MEDICINE
- 68Ga-PSMA PET/CT vs. mpMRI for locoregional prostate cancer staging: correlation with final histopathology
- (2018) I. Berger et al. PROSTATE CANCER AND PROSTATIC DISEASES
- PSMA expression: a potential ally for the pathologist in prostate cancer diagnosis
- (2018) Sara Bravaccini et al. Scientific Reports
- Immunohistochemical Validation of PSMA Expression Measured by68Ga-PSMA PET/CT in Primary Prostate Cancer
- (2017) Nadine Woythal et al. JOURNAL OF NUCLEAR MEDICINE
- Phase 2 Study of 99m Tc-Trofolastat SPECT/CT to Identify and Localize Prostate Cancer in Intermediate- and High-Risk Patients Undergoing Radical Prostatectomy and Extended Pelvic LN Dissection
- (2017) Karolien E. Goffin et al. JOURNAL OF NUCLEAR MEDICINE
- 99m Tc-MIP-1404-SPECT/CT for the detection of PSMA-positive lesions in 225 patients with biochemical recurrence of prostate cancer
- (2017) Christian Schmidkonz et al. PROSTATE
- Diagnostic sensitivity of Tc-99m HYNIC PSMA SPECT/CT in prostate carcinoma: A comparative analysis with Ga-68 PSMA PET/CT
- (2017) Ismaheel O. Lawal et al. PROSTATE
- Sensitivity, Specificity, and Predictors of Positive 68 Ga–Prostate-specific Membrane Antigen Positron Emission Tomography in Advanced Prostate Cancer: A Systematic Review and Meta-analysis
- (2016) Marlon Perera et al. EUROPEAN UROLOGY
- Preclinical Evaluation and First Patient Application of 99m Tc-PSMA-I&S for SPECT Imaging and Radioguided Surgery in Prostate Cancer
- (2016) Stephanie Robu et al. JOURNAL OF NUCLEAR MEDICINE
- Prostate-specific Membrane Antigen–radioguided Surgery for Metastatic Lymph Nodes in Prostate Cancer
- (2015) Tobias Maurer et al. EUROPEAN UROLOGY
- ESUR prostate MR guidelines 2012
- (2012) Jelle O. Barentsz et al. EUROPEAN RADIOLOGY
- Is there still a role for SPECT–CT in oncology in the PET–CT era?
- (2012) Rodney J. Hicks et al. Nature Reviews Clinical Oncology
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started